Emily Pei-Ying Lin

View Scopus Profile

Emailemilypylintmu.edutw, 201007h.tmu.edutw

h-index

Research activity per year

Education

2008-2015 Ph.D, Taiwan International Graduate Program-The Molecular Medicine Program, Academia Sinica and National Yang Ming University
1996-2003 M.D.,College of Medicine, Taipei Medical University

Experience

2023- Adjoint Associate Professor, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2023- Associate Professor (Joint Appointment), Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
2023- Associate Professor (Joint Appointment), Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
2023- Associate Professor, School and College of Medicine, Taipei Medical University, Taipei, Taiwan
2021- Director, Center for Precision Health and Quantitative Sciences, Taipei Medical University Hospital, Taipei, Taiwan
2020- Attending Physician, Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan
2022 Coordinator, Precision Oncology Team, Taipei Medical University
2021-2023 Associate Director, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
2021-2023 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
2021-2022 Director, Center for Precision Medicine and Translational Cancer Research, Taipei Medical University Hospital, Taipei, Taiwan
2020-2023 Adjoint Assistant Professor, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2020 Assistant Professor, College of Medicine, Fu Jen Catholic University
2020 Attending Physician of Chest Medicine and Director of Medical Research, Fu Jen Catholic University Hospital, New Taipei City, Taiwan
2018-2020 Visiting Scholar, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2015-2019 Attending Physician, Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
2015-2018 Adjunct Attending Physician, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
2008-2019 Adjunct Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2006-2008 Clinical Fellow, Division of Chest Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2003-2006 Resident, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2002-2003 Rotating Intern, National Taiwan University Hospital, Taipei, Taiwan

Awards

2024 TOS Young Investigator Award for Cancer Research, Taiwan.
2022 Outstanding Research Award, Taipei Medical University, Taipei, Taiwan
2020 VICTR award. Vanderbilt University Medical Center, Nashville, TN, USA.
2019 Fellowship award, Method in Clinical Cancer Research. Zeist, Netherland.
2019 Fellowship award, IASLC Targeted Therapies of Lung Cancer Meeting. Santa Monica, CA, USA.
2016 Young investigator communication workshop award. WCLC. Vienna, Austria.
2011 Outstanding presentation award. Joint Molecular Medicine Program Retreat. Institute of Biomedical Sciences, Academia Sinica, Taiwan
2009 Fellowship award, Molecular Biology in Clinical Oncology. Aspen, CO, USA.
2009 AACR-ITO EN, Ltd. Scholar-in-Training Award. The 100^th AACR Annual Meeting. Denvor, CO, USA.
2003 Dr. Tu Tsung-Ming award

Research Interests

Internal Medicine
Pulmonary and Critical Care Medicine
Thoracic Oncology
Cancer Biology and Molecular Cancer Biology
Translational Cancer Research
Precision Medicine and Precision Oncology

Fingerprint

Dive into the research topics where Emily Pei-Ying Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Active
8 Finished

Reshaping Tumor Microenvironment in Lung Cancer: Turning Cold into Hot
Lin, E.P.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Tackling Leptomeningeal Carcinomatosis and Cancer-Associated Cachexia in Lung Cancer
Lin, E.P.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Reshaping Tumor Microenvironment in Lung Cancer: Turning Cold into Hot
Lin, E.P.-Y. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
針對表皮生長因子受體研發肺癌治療之抑制型胜肽藥物
Lin, E.P.-Y. (PI)
1/1/23 → 12/31/23
Project: A - Government Institution › a - National Health Research Institutes
Overcoming Barriers in Lung Cancer Therapy: Delivery, Targeting, and Resistance
Lin, E.P.-Y. (PI)
8/1/22 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council

26 Article
3 Review article
2 Editorial
1 Letter
More
- 1 Short survey

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection
COVID-19 and Cancer Consortium, Apr 2025, In: The Lancet Regional Health - Americas. 44, 101038.
Research output: Contribution to journal › Article › peer-review

Open Access
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies
Yang, H. C., Kwok, P. Y., Li, L. H., Liu, Y. M., Jong, Y. J., Lee, K. Y., Wang, D. W., Tsai, M. F., Yang, J. H., Chen, C. H., Yeh, E. C., Wei, C. Y., Fann, C. S. J., Huang, Y. T., Chen, C. W., Lee, Y. J., Chu, S. K., Ho, C. H., Yang, C. S. & Lee, Y. L. & 123 others, Chen, H. H., Hou, M. C., Chiou, J. F., Yang, S. F., Wang, C. H., Huang, C. Y., Chiu, K. M., Chen, M., Chiang, F. T., Lee, S. L., Chen, S. S., Yao, W. J., Chien, C. C., Lin, S. Y., Chang, F. P., Ho, H. L., Yeh, Y. C., Tseng, W. C., Lin, M. H., Chang, H. T., Tseng, L. M., Liang, W. Y., Chen, P. C. H., Hang, J. F., Lin, S. C., Chan, Y. J., Kuo, Y. J., Wang, L. C., Pan, C. C., Hsieh, Y. C., Chen, Y. M., Hsiao, T. H., Lin, C. H., Chen, Y. J., Chen, I. C., Mao, C. L., Chang, S. J., Chang, Y. L., Liao, Y. J., Lai, C. H., Lee, W. J., Tung, H., Yen, T. T., Yen, H. C., Shih, C. M., Chou, T. Y., Liou, T. H., Chiang, C. Y., Cherng, Y. G., Chen, C. H., Chiu, C. H., Tseng, S. H., Lin, E. P. Y., Chen, Y. J., Chuang, H. P., Chen, T. C., Huang, W. T., Sin, J., Liu, I. L., Chen, Y. C., Chao, K. K., Wu, Y. M., Yu, P. P., Chang, L. P., Yen, K. Y., Chang, L. C., Sheen, Y. J., Chen, Y. T., Kan, K., Tsai, H. L., Wang, Y. K., Hou, M. F., Yang, Y. H., Kuo, C. H., Wu, W. J., Huang, J. F., Chong, I. W., Tsai, J. R., Lin, C. Y., Yu, M. C., Lee, T. H., Tsai, M. H., Ou, Y. C., Chen, P. Y., Hu, T. H., Shyu, Y. C., Cheng, C. K., Fang, Y. J., Hsieh, S. C., Chen, C. H., Chen, C. C., Li, K. J., Lin, C. H., Chiu, H. Y., Wu, C. C., Chen, C. Y., Chu, S. J., Liu, F. C., Yang, F. C., Chang, H. A., Chen, W. L., Yang, S. S., Sung, Y. F., Wang, T. F., Lin, S. Z., Wu, Y. W., Wu, C. S., Jiang, J. Y., Ma, G. C., Chang, T. Y., Hwang, J. J., Kao, K. J., Hung, C. F., Chiu, T. F., Chen, P. Y., Tsui, K., Wu, M. S., Pang, S. T., Chen, S. A., Chen, W. M., Chen, C. H., Sheu, W. H. H. & Wu, J. Y., Dec 4 2025, In: Nature. 648, 8092, p. 117-127 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
8 Link opens in a new tab Citations (Scopus)
AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis
Huang, B. T., Lai, W. Y., Yeh, C. L., Tseng, Y. T., Peck, K., Yang, P. C. & Lin, E. P. Y., Oct 15 2024, In: ACS Nano. 18, 41, p. 27905-27916 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
11 Link opens in a new tab Citations (Scopus)
Analysis of Cancer Survival Associated with Immune Checkpoint Inhibitors after Statistical Adjustment: A Systematic Review and Meta-analyses
Lin, E. P. Y., Hsu, C. Y., Berry, L., Bunn, P. & Shyr, Y., Aug 17 2022, In: JAMA network open. 5, 8, p. E2227211
Research output: Contribution to journal › Review article › peer-review

Open Access
23 Link opens in a new tab Citations (Scopus)
Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors
Lin, E. P. Y., Huang, L. C., Whisenant, J., York, S., Osterman, T., Lewis, J., Iams, W., Skotte, E., Cass, A., Hsu, C. Y., Shyr, Y. & Horn, L., Oct 1 2022, In: ERJ Open Research. 8, 4, 00684-2021.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Link opens in a new tab Citations (Scopus)

Emily Pei-Ying Lin

Personal profile

Education

Experience

Awards

Research Interests

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Reshaping Tumor Microenvironment in Lung Cancer: Turning Cold into Hot

Tackling Leptomeningeal Carcinomatosis and Cancer-Associated Cachexia in Lung Cancer

Reshaping Tumor Microenvironment in Lung Cancer: Turning Cold into Hot

針對表皮生長因子受體研發肺癌治療之抑制型胜肽藥物

Overcoming Barriers in Lung Cancer Therapy: Delivery, Targeting, and Resistance

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies

AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis

Analysis of Cancer Survival Associated with Immune Checkpoint Inhibitors after Statistical Adjustment: A Systematic Review and Meta-analyses

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

Emily Pei-Ying Lin

Personal profile

Education

Experience

Awards

Research Interests

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output